• Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D & Hallal PC (2008) A descriptive review of the methodologies used in household surveys on medicine utilization. BMC Health Services Research 8, 222.
  • Bjerrum L, Munck A, Gahrn-Hansen B et al. (2010) Health alliance for prudent prescribing, yield and use of antimicrobial drugs in the treatment of respiratory tract infections (HAPPY AUDIT). BMC Family Practice 11, 29.
  • Coker TR, Chan LS, Newberry SJ et al. (2010) Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA 304, 21612169.
  • Crawley J, Chu C, Mtove G & Nosten F (2010) Malaria in children. Lancet 375, 14681481.
  • Dikassa P, Kebede D, Soumbey-Alley E & Sambo L (2010) Strengthening the monitoring of progress on the health-related MDGs in the African region. The African Health Monitor 11, 39.
  • Ferech M, Coenen S, Malhotra-Kumar S et al. (2006) European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe. Journal of Antimicrobial Chemotherapy 58, 401407.
  • Holloway KA, Ivanovska V, Ross-Degnan D et al. (2009) Medicines use in primary care in developing and transitional countries. WHO, Geneva.
  • International Network for Rational Use of Drugs, WHO (1993) How to investigate drug use in health facilities: Selected drug use indicators. WHO, Geneva.
  • Kristiansson C, Reilly M, Gotuzzo E et al. (2008) Antibiotic use and health-seeking behaviour in an underprivileged area of Peru. Tropical Medicine and International Health 13, 434441.
  • Nordberg P, Monnet DL & Cars O (2004) Antibacterial Drug Resistance. [Background document] Priority Medicines for Europe and the World “A Public Health Approach to Innovation”. WHO, Geneva.
  • Nugent R, Back E & Beith A (2010) The race against drug resistance. Center for Global Development, Washington DC.
  • Nweneka CV, Tapha-Sosseh N & Sosa A (2009) Curbing the menace of antimicrobial resistance in developing countries. Harm Reduction Journal 6, 31.
  • Okeke IN, Laxminarayan R, Bhutta ZA et al. (2005) Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infectious Diseases 5, 481493.
  • Radyowijati A & Haak H (2003) Improving antibiotic use in low-income countries: an overview of evidence on determinants. Social Science and Medicine 57, 733744.
  • Victora CG, Adam T, Bryce J & Evans DB (2006) Integrated management of the sick child. In: Disease Control Priorities in Developing Countries (eds D Jamison, J Breman, A Measham, M Claeson, D Evans & P Jha et al. ) World Bank, Washington DC: Chapter 63.
  • Wafula FN & Goodman CA (2010) Are interventions for improving the quality of services provided by specialized drug shops effective in sub-Saharan Africa? A systematic review of the literature International Journal for Quality in Health Care 22, 316323.
  • Winter J (2004) Response bias in survey-based measures of household consumption. Economics Bulletin, 3, 112.
  • World Health Organization (2001) WHO Global Strategy for Containment of Antimicrobial Resistance. WHO, Geneva.
  • World Health Organization (2007a) WHO Operational package for assessing, monitoring and evaluating country pharmaceutical situations. WHO, Geneva.
  • World Health Organization (2007b) WHO Model List of Essential Medicines, 15th edn. WHO, Geneva.
  • World Health Organization (2008) Manual for the Household Survey to Measure Access and Use of Medicines (Draft). WHO, Geneva.
  • World Health Organization (2009) Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings: Report on five pilot projects. WHO, Geneva.
  • World Health Organization (2011) The World Medicines Situation. WHO, Geneva.
  • Wutzke SE, Artist MA, Kehoe LA, Fletcher M, Mackson JM & Weekes LM (2007) Evaluation of a national programme to reduce inappropriate use of antibiotics for upper respiratory tract infections: effects on consumer awareness, beliefs, attitudes and behaviour in Australia. Health Promotion International 22, 5364.